MWMary C. Weiss

Mary C. Weiss

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mary C. Weiss has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Helene Strick-Marchand

    Institut Pasteur, Université Paris Cité, Inserm U1223, Innate Immunity Unit, 75015 Paris, France

    6 shared publications
  • Daniela M. Faust

    Unité de Génétique de la Différenciation, Unité de Recherche Associée 2578 du Centre National de la Recherche Scientifique, Paris, France

    4 shared publications
  • Dina Kremsdorf

    INSERM, U845, Pathogenèse des Hépatites Virales B et Immunothérapie, Paris 75015, France

    4 shared publications
  • Serban Morosan

    Institut National de la Santé et de la Recherche Médicale U845, Pathogénèse des Hépatites Virales B et Immunothérapie, CHU Necker, 156 rue de Vaugirard, 75015 Paris, France

    3 shared publications
  • Anne-Marie Catherin

    Unité de Génétique de la Différenciation, FRE 2364, Centre National de la Recherche Scientifique, Département de Biologie Moléculaire, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris, France

    2 shared publications
  • Pierre Charneau

    Laboratoire de Virologie Moléculaire et Vectorologie, Institut Pasteur, Paris, France

    2 shared publications

Latest Publications

  • Open Access

    Progressive developmental restriction, acquisition of left-right identity, and cell growth behavior during lobe formation in mouse liver development

    by Mary C. Weiss, Jean-Francois Le Garrec, Sabrina Coqueran, Helene Strick-Marchand, Margaret Buckingham

    To identify cell-based decisions implicated in morphogenesis of the mammalian liver, we performed clonal analysis of hepatocytes/hepatoblasts in mouse liver development, using a knock-in allele of HNF4α/laacZ. This transgene randomly undergoes a low frequency of recombination that generates a functional lacZ gene that produces β-galactosidase in tissues where HNF4α is expressed. Two types of β-galactosidase-positive clones were found. Most have undergone 3-8 cell divisions and result from independent events (Luria-Delbruck fluctuation test); we calculate that they arose between E8.5 and E13.5. A second class was mega-clones derived from early endoderm progenitors, generating many descendants. Some originated from multi-potential founder cells, with labeled cells in the liver, pancreas and/or intestine. A few mega-clones populate only one side of the liver, indicating hepatic cell chirality. The patterns of labeled cells indicate cohesive and often oriented growth, notably in broad radial stripes, potentially implicated in the formation of liver lobes. This retrospective clonal analysis gives novel insights into clonal origins, cell behavior of progenitors and distinct properties of endoderm cells that underlie the formation and morphogenesis of the liver.


  • Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens

    by Nicolas Brezillon, Dina Kremsdorf, Mary C. Weiss

    It has long been known that hepatocytes possess the potential to replicate through many cell generations because regeneration can be achieved in rodents after serial two-thirds hepatectomy. It has taken considerable time and effort to harness this potential, with liver regeneration models involving hepatocyte transplantation developing over the past 15 years. This review will describe the experiments that have established the models and methodology for liver repopulation, and the use of cells other than adult hepatocytes in liver repopulation, including hepatic cell lines and hematopoietic, cord blood, hepatic and embryonic stem cells. Emphasis will be placed on the characteristics of the models and how they can influence the outcome of the experiments. Finally, an account of the development of murine models that are competent to accept human hepatocytes is provided. In these models, liver deficiencies are induced in immunodeficient mice, where healthy human cells have a selective advantage. These mice with humanized livers provide a powerful new experimental tool for the study of human hepatotropic pathogens.


  • Morphogenetic competence of HNF4α-deficient mouse hepatic cells

    by Graham P. Hayhurst, Hélène Strick-Marchand, Céline Mulet, Anne-Françoise Richard, Serban Morosan, Dina Kremsdorf, Mary C. Weiss


  • Plasticity of Hepatic Cell Differentiation: Bipotential Adult Mouse Liver Clonal Cell Lines Competent to Differentiate In Vitro and In Vivo

    by Catherine Fougère‐Deschatrette, Tereza Imaizumi‐Scherrer, Hélène Strick‐Marchand, Serban Morosan, Pierre Charneau, Dina Kremsdorf, Daniela M. Faust, Mary C. Weiss

    In fetal liver, bipotential hepatoblasts differentiate into hepatocytes and bile duct cells (cholangiocytes). The persistence of such progenitor cells in adult mouse liver is still debated. In damaged liver of adult murine animals, when hepatocyte proliferation is compromised, bipotential oval cells emerge, probably from bile ducts, proliferate, and differentiate to regenerate the liver. However, treatment to elicit oval cell proliferation is not necessary to obtain bipotential stem cells from adult mouse liver. Here, we have isolated bipotential clonal cell lines from healthy liver of 8–10‐week‐old C57BL/6 mice. Primary cultures established from hepatocyte‐enriched suspensions were characterized by time‐lapse image acquisition, immunocytology, and RNA transcript analysis. Although hepatocytes dedifferentiated with loss of apical polarity and other hepatocyte markers, they rapidly activated expression of bile duct/oval cell markers. Reversibility of these processes was achieved in part by culture under dilute Matrigel or by aging of confluent cultures. Cell lines were obtained at high frequency from mass cultures, from isolated colonies, and by primary cloning of the hepatocyte‐enriched suspension. Cells of the clonal cell lines do not grow in soft agar and are nontumorigenic, and they express cytokeratin 19, A6 antigen, and α6 integrin, as well as a large panel of hepatocyte functions. Furthermore, they can participate in liver regeneration in albumin‐urokinase‐type plasminogen activator/severe combined immune‐deficient mice, where they differentiate in clusters of hepatocytes and occasionally bile ducts. These results demonstrate the existence, in normal adult mouse liver, of a significant pool of clonogenic cells that are (or can become) bipotential.


  • Open Access

    In vivo role of the HNF4α AF‐1 activation domain revealed by exon swapping

    by Nadège Briançon, Mary C Weiss

    The gene encoding the nuclear receptor hepatocyte nuclear factor 4α (HNF4α) generates isoforms HNF4α1 and HNF4α7 from usage of alternative promoters. In particular, HNF4α7 is expressed in the pancreas whereas HNF4α1 is found in liver, and mutations affecting HNF4α function cause impaired insulin secretion and/or hepatic defects in humans and in tissue‐specific ‘knockout’ mice. HNF4α1 and α7 isoforms differ exclusively by amino acids encoded by the first exon which, in HNF4α1 but not in HNF4α7, includes the activating function (AF)‐1 transactivation domain. To investigate the roles of HNF4α1 and HNF4α7 in vivo , we generated mice expressing only one isoform under control of both promoters, via reciprocal swapping of the isoform‐specific first exons. Unlike Hnf4 α gene disruption which causes embryonic lethality, these ‘α7‐only’ and ‘α1‐only’ mice are viable, indicating functional redundancy of the isoforms. However, the former show dyslipidemia and preliminary results indicate impaired glucose tolerance for the latter, revealing functional specificities of the isoforms. These ‘knock‐in’ mice provide the first test in vivo of the HNF4α AF‐1 function and have permitted identification of AF‐1‐dependent target genes.


  • Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes

    by Hélène Strick-Marchand, Serban Morosan, Pierre Charneau, Dina Kremsdorf, Mary C. Weiss

    Cell lines have many advantages: they can be manipulated genetically, expanded, and stockpiled for organ transplantation. Freshly isolated hepatocytes, oval cells, pancreatic cells, and hematopoietic stem cells have been shown to repopulate the damaged liver. Here we show that bipotential mouse embryonic liver (BMEL) stem cell lines participate in liver regeneration in albumin–urokinase plasminogen activator/severe combined immunodeficiency disease (Alb-uPA/SCID) transgenic mice. In the liver, BMEL-GFP cells proliferate and differentiate into both hepatocytes and bile ducts, forming small to large clusters detected throughout the 3–8 weeks analyzed after transplantation. Moreover, they respond like host cells to signals for growth, differentiation, and even zonal expression of metabolic enzymes, showing regulated expression of cytokeratins and liver-enriched transcription factors. Immunostaining for MHC class I molecules revealed that cells do not coexpress donor and recipient H-2 haplotypes, as would be the case had cell fusion occurred. This report shows that immortalized stem cell lines not only are competent to participate in the repair of a damaged tissue but also can differentiate into the two major epithelial cell types of a complex organ, hepatocytes and bile ducts.


  • Isolation and Characterization of Mouse Hepatic Stem Cells in Vitro

    by Mary C. Weiss, Hélène Strick-Marchand

    This article covers mouse cell lines showing the properties of hepatoblasts or oval cells and describes hepatocyte differentiation obtained from embryonic stem (ES) cells and mesenchymal adult progenitor cells. It considers the methods used for cultivation and differentiation of the cells, as well as the strengths and weaknesses of the different systems and perspectives for future research. Emphasis is given to hepatoblast cell lines because this is the material for which bipotentiality has been most clearly demonstrated and for which proliferation and differentiation conditions have been worked out.


  • Open Access

    Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos

    by Hélène Strick-Marchand, Mary C. Weiss

    This work shows that hepatic cell lines reproducibly can be derived from E14 embryos of many mouse inbred strains. These bipotential mouse embryonic liver (BMEL) cell lines present a mixed morphology, containing both epithelial and palmate-like cells, and an uncoupled phenotype, expressing hepatocyte transcription factors (HNF1α, HNF4α, GATA4) but not functions (apolipoproteins, albumin). BMEL cells are bipotential: under inducing conditions they express hepatocyte and bile duct functions. In addition, they can undergo morphogenesis in Matrigel culture to form bile duct units. When returned to basal culture conditions, the differentiated cells revert, within a few days, to an undifferentiated state. The ensemble of markers expressed by BMEL cells implies that they originate from hepatoblasts, the endodermal precursors of the liver. In conclusion, the establishment of a simple and reproducible method to isolate from any mouse embryo bipotential hepatic cell lines that exhibit the properties of transit stem cells provides a novel paradigm for investigation of hepatic cell lineage relationships.


  • Open Access

    An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors

    by Alain Bailly, Maria Elena Torres-Padilla, Antoine P. Tinel, Mary C. Weiss

    We have characterized a 700 bp enhancer element around –6 kb relative to the HNF4α1 transcription start. This element increases activity and confers glucocorticoid induction to a heterologous as well as the homologous promoters in differentiated hepatoma cells and is transactivated by HNF4α1, HNF4α7, HNF1α and HNF1β in dedifferentiated hepatoma cells. A 240 bp sub-region conserves basal and hormone-induced enhancer activity. It contains HNF1, HNF4, HNF3 and C/EBP binding sites as shown by DNase I footprinting and electrophoretic mobility shift assays using nuclear extracts and/or recombinant HNF1α and HNF4α1. Mutation analyses showed that the HNF1 site is essential for HNF1α transactivation and is required for full basal enhancer activity, as is the C/EBP site. Glucocorticoid response element consensus sites which overlap the C/EBP, HNF4 and HNF3 sites are crucial for optimal hormonal induction. We present a model that accounts for weak expression of HNF4α1 in the embryonic liver and strong expression in the newborn/adult liver via the binding sites identified in the enhancer.